Related Experiment Videos

[Epidemiology of community-acquired pneumonia in children. Current data]

C Marguet1, N Bocquel, E Mallet

  • 1Unité des maladies respiratoires de l'enfant, hôpital Charles-Nicolle, Rouen, France.

Insights

Respiratory infections in children are often caused by viruses in infants and bacteria in older children. Antimicrobial resistance and increasing morbidity necessitate careful treatment strategies for community-acquired infections.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Epidemiology

Context:

  • Community-acquired lower respiratory tract infections (LRTI) are a significant concern in pediatric populations.
  • Viral pathogens, such as syncitial respiratory virus, dominate infant LRTI, while bacterial agents are more prevalent in children over 3 years old.
  • Emerging antimicrobial resistance in key bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae) and high rates of atypical pneumonia (Mycoplasma pneumoniae, Chlamydia pneumoniae) complicate treatment decisions.

Purpose:

  • To outline the primary etiological agents of community-acquired lower respiratory tract infections in different pediatric age groups.
  • To highlight the challenges in antimicrobial therapy due to evolving pathogen resistance and common atypical infections.
  • To report trends in mortality and morbidity of pediatric respiratory infections in France.

Summary:

  • Syncitial respiratory virus is a primary cause of LRTI in infants, with bacterial pathogens more common in older children.
  • Treatment considerations include reduced susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to penicillin and beta-lactamase, alongside frequent Mycoplasma pneumoniae and Chlamydia pneumoniae infections.
  • While mortality rates remain low in France, there has been a recent increase in the morbidity associated with these infections.

Impact:

  • Informing clinical practice for the appropriate management of pediatric respiratory infections.
  • Guiding antimicrobial stewardship by emphasizing the need to consider resistance patterns.
  • Highlighting the growing public health burden of pediatric respiratory morbidity in developed countries.

Related Concept Videos